Bigfoot Biomedical is a medical device company headquartered in Milpitas, California that developed the Bigfoot Unity smart insulin management system. The system features FDA-cleared connected insulin pen caps that translate continuous glucose monitor data into insulin dosing recommendations. The company was founded in 2014 by Jeffrey Brewer (former JDRF CEO), Bryan Mazlish, and Lane Desborough (former Medtronic chief engineer). Bigfoot Unity works with FreeStyle Libre 2 sensors and all major brands of disposable insulin pens, approved for patients 12 years and older requiring multiple daily insulin injections. Abbott Laboratories completed acquisition of Bigfoot Biomedical on September 22, 2023.
Bigfoot Biomedical has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2014
Employees
51–200
Total Funding
$146M
6 rounds
Total raised $146M across 6 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 05-07-2026
Latest Round
Type
Series C Extension
Date
June 2020
Amount
$10M
Valuation
—
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| June 2020 | Series C Extension | $10M | — | |
| January 2020 | Series C | $45M | — | |
| June 2018 | Series B Extension | $18M | — |
Jeffrey Brewer
Cofounder, President & CEO
Bryan Mazlish
Cofounder
Lane Desborough
Cofounder, Chief Engineer
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Medtronic
Offers InPen smart insulin pen system integrated with Guardian Connect continuous glucose monitoring for multiple daily injection therapy
Novo Nordisk
Produces NovoPen 6 and NovoPen Echo Plus smart insulin pens; acquired minority stake in Bigfoot Biomedical in July 2023
Eli Lilly
Developed Tempo Pen and Tempo Smart Button personalized diabetes management platform; compatible with Bigfoot capware
Sanofi
Major insulin manufacturer with smart insulin pen offerings; Bigfoot caps compatible with Sanofi rapid- and long-acting pens
Roche
Glucose monitoring and diabetes management company; partnered with Novo Nordisk on mySugr integration for smartpen data logging
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.